TESARO Inc.

(TSRO)

By |

Profile

Tesaro Inc is an oncology-focused biopharmaceutical company engaged in improving the lives of cancer patients. It develops oncology-related product candidates, including rolapitant, niraparib, and the product candidates under immuno-oncology platform.

Contact Information

Website: www.tesarobio.com
Main Phone: +1 339 970-0900
Address: 1000 Winter Street
Address 2: Suite 3300
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NGS
Employees: 286
NAICS: Pharmaceutical P
$ 132.37 ($ 2.48) (-1.84%)
Last Price 132.37 Change $ -2.48 Change % -1.84 Tick N/A
Bid 132.25 Bid Size 300.00 Ask 132.59 Ask Size 100.00
Open 134.12 High 135.38 Low 129.07 Prev Close 134.85
Last Trade Volume 267,877 52 Wk Hi 148.74 52 Wk Low 29.51
Market Cap 7.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 53,412,407.00 EPS (TTM) -7.37 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 12 47
Number of Buys 8 36
Number of Sells 4 11
Net Activity 7296 12650227
Last 10 Buys Shares
Arnold L. Oronsky 1,000
Beth C. Seidenberg 1,000
Beth C. Seidenberg 1,000
Krishna Kolluri 1,000
Harry R. Weller 1,000
Harry R. Weller 1,000
Forest Baskett 1,000
Ravi Viswanathan 1,000
Ravi Viswanathan 1,000
Krishna Kolluri 1,000
Last 10 Sell Shares
Jeffrey H. Hanke 1,000
Jeffrey H. Hanke 1,000
Edward C. English 1,000
Edward C. English 1,000
Edward C. English 1,000
Edward C. English 1,000
Edward C. English 1,000
Edward C. English 1,000
Ravi Viswanathan 1,000
Ravi Viswanathan 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 114 114 114 114
Low Target Price Estimate 80 80 75 80
Mean Target Price Estimate 102.33 102 96.63 102.33
Standard Deviation 9.45 10.04 11.4 9.45
Date of Most Recent Estimate 08/05/16 08/05/16 07/19/16 08/05/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 9 8 8 8
Moderate Buy 1 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.27 1.22 1 1